TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0260
0.00 (0.00%)
At close: Oct 24, 2025
TrivarX Revenue
In the fiscal year ending June 30, 2025, TrivarX had annual revenue of 1.03M AUD with 16.00% growth. TrivarX had revenue of -97.63K in the half year ending June 30, 2025, a decrease of -33,420.14%.
Revenue
1.03M
Revenue Growth
+16.00%
P/S Ratio
15.63
Revenue / Employee
171.85K
Employees
6
Market Cap
16.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.03M | 142.24K | 16.00% |
| Jun 30, 2024 | 888.83K | -71.62K | -7.46% |
| Jun 30, 2023 | 960.45K | -45.00K | -4.48% |
| Jun 30, 2022 | 1.01M | -258.10K | -20.43% |
| Jun 30, 2021 | 1.26M | 338.28K | 36.56% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |